San Diego-based Celladon has made a big splash in the U.K. British scientists are playing a prominent role in a pair...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
BUSINESS OF BIOTECHNOLOGY
They're perfecting scientific developments that could cure the world's toughest diseases, improve food production, and even yield energy alternatives. This is the exciting world of biotechnology, where young companies fight to make innovative discoveries -- and to find new and innovative ways of funding those innovations.
Business of Biotechnology is part of Business Exchange, suggested by
Arlene Weintraub.
This topic contains
1,250 news
and
4,718 blog
items.
Read updated news, blogs, and resources about Business of Biotechnology. Find user-submitted articles and reactions on Business of Biotechnology from
like-minded professionals.
Blogs
Recent blog posts on this topic.
Cambridge, MA-based Moderna Therapeutics has scored another coup. The biotech, which struck a major development deal...
Up until now, the FDA has reserved its new "breakthrough" designation for a Who's Who in drug development,...
Regulators at the FDA have weighed the data for Aveo's tivozanib, raising a simple question that could prove vexing for...
David J. Mazzo, president and CEO of Regado Biosciences Late last year Regado Biosciences came up with a big $51...
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Forma Therapeutics has locked in another biopharma partner. The biotech giant Celgene ($CELG) and Forma have agreed to...
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Last year AstraZeneca's (NYSE:AZN) MedImmune did about 20 biologics deals, not counting the academic pacts it assembled.
What if you had a great combination of rival drugs that worked in 100% of patients but one of the companies involved...
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
San Diego-based Receptos, which made known its plans to go public weeks ago, has proposed a price range of $14 to $16...
Back in early 2012, a number of physicians around the U.S. began fielding some unusual requests from Alzheimer's...
The German biotech Evotec and Johnson & Johnson ($JNJ) have the inside track on drug development based on a Harvard...
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Top Sources: Business of Biotechnology
- Biotech Blog
- News
- Health Beat
- frontendofinnovation.blogspot.com
- Nature Biotechnology
- The Biotech Weblog
- policyinnovations.org
- Science Progress
- LinkedIn Answers: Technology
- World Pharma News / Published News
account